Jean-Charles Tschudin
Corporate Officer/Principal chez Georgetown University
Profil
Jean-Charles Tschudin is a Chartered Director at Georgetown University.
He previously served as a Senior Independent Director at SkyePharma Plc from 2014 to 2015, a Non-Executive Director at Sinclair Pharma Plc from 2007 to 2011, and a Senior Independent Non-Executive Director at Sinclair Pharma Ltd.
from 2012 to 2016.
He also served as President & Chief Operating Officer at Yamanouchi Europe B.V.
Tschudin received his undergraduate degree from Georgetown University.
Postes actifs de Jean-Charles Tschudin
Sociétés | Poste | Début |
---|---|---|
Georgetown University | Corporate Officer/Principal | 22/11/2010 |
Anciens postes connus de Jean-Charles Tschudin
Sociétés | Poste | Fin |
---|---|---|
SINCLAIR PHARMA PLC | Director/Board Member | 19/07/2016 |
SKYEPHARMA PLC | Director/Board Member | 31/12/2015 |
Sinclair Pharma Plc /Old/
Sinclair Pharma Plc /Old/ Pharmaceuticals: MajorHealth Technology Sinclair Pharma Plc is a specialty pharmaceutical company. It provides solutions to treat wounds, which include skin disinfection, radiation dermatitis treatment and wounds and burns healing; dermatology, which include fungal infections, acne, atopic dermatitis and family dermatology; as well as oral diseases, which include gingivitis, periodontitis, mouth ulcers and teething through advanced surface technology and innovative delivery systems. The company was founded by Andrew Sinclair in 1971 and is headquartered in Godalming, the United Kingdom. | Director/Board Member | 27/06/2011 |
Yamanouchi Europe B.V. | President | - |
Formation de Jean-Charles Tschudin
Georgetown University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
SkyePharma Plc
SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
Sinclair Pharma Plc /Old/
Sinclair Pharma Plc /Old/ Pharmaceuticals: MajorHealth Technology Sinclair Pharma Plc is a specialty pharmaceutical company. It provides solutions to treat wounds, which include skin disinfection, radiation dermatitis treatment and wounds and burns healing; dermatology, which include fungal infections, acne, atopic dermatitis and family dermatology; as well as oral diseases, which include gingivitis, periodontitis, mouth ulcers and teething through advanced surface technology and innovative delivery systems. The company was founded by Andrew Sinclair in 1971 and is headquartered in Godalming, the United Kingdom. | Health Technology |
Yamanouchi Europe B.V. | |
Sinclair Pharma Ltd.
Sinclair Pharma Ltd. Medical SpecialtiesHealth Technology Sinclair Pharma Ltd. operates as an aesthetic dermatology company which provides solutions through collagen stimulation for facial volume loss, thread lifting for facial contouring, and dermal fillers for wrinkles and lines. It operates through the following business segments: Country Operations and International Operations. The Country Operations segment comprises the proprietary sales infrastructure from the operations in France, the United Kingdom, Italy, Germany, and Spain. The International Operations segment focuses on the sale through a local distributor. The company was founded in 1971 and is headquartered in London, the United Kingdom. | Health Technology |